In a new paper published today in the journal Addiction, researchers from Loyola University found that individuals with opioid use disorder using Ozempic had a 40 percent lower rate of overdose compared to those not on the medication. Similarly, those with alcohol use disorder had a 50 percent lower rate of alcohol intoxication when treated with Ozempic. These results suggest that Ozempic may have potential beyond diabetes and weight loss, opening avenues for addiction treatment research.
The retrospective study analyzed data from electronic health records of over 1 million people, examining records from 503,747 people with opioid use disorder and 817,309 with a history of alcohol use disorder. Of these, 8,103 people with opioid use disorder and 5,621 with alcohol use disorder were identified as being on GLP-1 receptor agonists or GIP, providing evidence of the drug's potential to mitigate addictive behaviors.
Collection
[
|
...
]